Citi Pharma Ltd. has announced a Board Meeting scheduled for October 30, 2026, to review financial statements and conduct other business.
- Meeting Date: October 30, 2026
- Time: 04:00 p.m.
- Agenda: Approval of Un-audited Unconsolidated and Consolidated Condensed Interim Financial Statements for the Quarter ended September 30, 2026
- Closed Period: October 24, 2026 to October 30, 2026 (inclusive)
- Directors and Executives are prohibited from trading shares during the Closed Period